Luprova 22.5mg Injection is a medication containing Leuprolide Acetate, a synthetic analog of gonadotropin-releasing hormone (GnRH). It works by initially stimulating the pituitary gland, leading to a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH). However, with continuous administration, it suppresses the release of these hormones, resulting in a significant decrease in sex hormone levels (testosterone in men and estrogen in women) to castrate levels. This hormonal suppression is the basis for its therapeutic effects in various hormone-dependent conditions.
Luprova 22.5mg Injection is indicated for the treatment of advanced prostate cancer, endometriosis, uterine fibroids, and precocious puberty. In men with advanced prostate cancer, it helps to reduce testosterone levels, slowing the growth of hormone-sensitive tumors. For women with endometriosis and uterine fibroids, it reduces estrogen levels, leading to shrinkage of endometrial implants and fibroids, respectively. In children with precocious puberty, it suppresses premature sexual development.
The typical dosage and administration schedule for Luprova 22.5mg Injection will be determined by a healthcare professional based on the specific condition being treated and the patient’s individual response. It is administered via intramuscular or subcutaneous injection. Common side effects may include hot flashes, decreased libido, erectile dysfunction, injection site reactions, and mood changes. Less common but serious side effects can occur, and patients should discuss any concerns with their doctor. Luprova 22.5mg Injection should be stored at room temperature, protected from light and moisture, and kept out of reach of children.
